SCHEMBL6086547

SCHEMBL6086547

CC1(C)CC(=O)c2cc(OS(=O)(=O)C(F)(F)F)ccc2O1

nearest known ligand 0.59

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 15/20 0.59
ALDH1A1 P00352 14/20 0.59
GAA P10253 10/20 0.59
HPGD P15428 8/20 0.59
GLA P06280 6/20 0.59
HSD17B10 Q99714 4/20 0.59
CASP1 P29466 3/20 0.59
CASP7 P55210 1/20 0.59
MAPT P10636 1/20 0.53
SMN1; SMN2 Q16637 2/20 0.51
NPC1 O15118 1/20 0.49
KLK7 P49862 1/20 0.48
MAOB P27338 4/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
NPSR1 Q6W5P4 1/20 0.46
MAPK1 P28482 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4010310 0.80 KDM4E (0.62) KDM4EALDH1A1GAAHPGDGLA
SCHEMBL6086511 0.79 KDM4E (0.65) KDM4EALDH1A1GAAHPGDGLA
SCHEMBL8771675 0.77 DRD2 (0.39) KDM4EALDH1A1KLK7
SCHEMBL6593106 0.77 ALDH1A1 (0.40) KDM4EALDH1A1GAAHPGDGLA
SCHEMBL6560822 0.77 KDM4E (0.62) KDM4EALDH1A1GAAHPGDGLA
SCHEMBL25857447 0.76 KDM4E (0.61) KDM4EALDH1A1GAAHPGDGLA
SCHEMBL4508350 0.75 ALDH1A1 (0.61) KDM4EALDH1A1GAAHPGDMAPT
SCHEMBL6087253 0.75 MAOB (0.43) ALDH1A1HPGDHSD17B10SMN1; SMN2NPC1
SCHEMBL1091438 0.75 PGR (0.45) KDM4EALDH1A1SMN1; SMN2
SCHEMBL1140782 0.74 CHRM1 (0.41) KDM4EALDH1A1SMN1; SMN2KLK7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7026487-B2 Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, a pyridyl group and an alkyl group, having retinoid-like biological activity ALLERGAN, INC. (US) 2006-04-11 US disclosed
US-20040097733-A1 Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity BEARD RICHARD L (US) 2004-05-20 US disclosed
US-20030166932-A1 Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity ALLERGAN SALES, INC. 2003-09-04 US disclosed
US-6613917-B1 Retinoid agonist, antagonist or negative hormone-like biological activity ALLERGAN, INC. 2003-09-02 US disclosed
EP-1265848-A2 AMINES SUBSTITUTED WITH A DIHYDRONAPHTHALENYL, CRHOMENYL, OR THIOCHROMENYL GROUP, AN ARYL OR HETEROARYL GROUP AND AN ALKYL GROUP, HAVING RETINOID-LIKE BIOLOGICAL ACTIVITY Allergan Sales, Inc. (US) 2002-12-18 EP disclosed
WO-2001070668-A2 AMINES SUBSTITUTED WITH A DIHYDRONAPHTHALENYL, CRHOMENYL, OR THIOCHROMENYL GROUP, AN ARYL OR HETEROARYL GROUP AND AN ALKYL GROUP, HAVING RETINOID-LIKE BIOLOGICAL ACTIVITY ALLERGAN, INC. (US) 2001-09-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030166932-A1 Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity NR4A1, NR2E3, NR0B1 KDM4E 2140/4885ALDH1A1 242/4885GAA 3926/4885
US-20040097733-A1 Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity NR4A1, NR2E3, NR0B1 KDM4E 2140/4885ALDH1A1 242/4885GAA 3926/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.